View clinical trials related to Vitrectomy.
Filter by:To perform a safety study on the prototype IRIS vitrectomy device.
This study seeks to evaluate the effect of the intravitreal 0.7mg dexamethasone implant on central macular thickness and visual acuity in those patients with persistent macular edema after pars plana vitrectomy for epiretinal membrane.
After an uneventfully small gauge vitrectomy we don´t think is necessary to occlude the eye for 24 hours